Will FDA approve any type of personalized cancer mRNA vaccines before 2028?
➕
Plus
12
Ṁ989
2027
84%
chance

Resolves YES if the FDA grants full approval for the commercial sale of any type of personalized cancer mRNA vaccines in the United States before January 1, 2028. This does not include emergency use authorization or other forms of limited authorization. Resolves NO otherwise.

Get
Ṁ1,000
and
S3.00
Sort by:

"Pancreatic Cancer Vaccine Shows Promise in Small Trial: Using mRNA tailored to each patient’s tumor, the vaccine may have staved off the return of one of the deadliest forms of cancer in half of those who received it."
https://www.nytimes.com/2023/05/10/health/pancreatic-cancer-vaccine-mrna.html

© Manifold Markets, Inc.Terms + Mana-only TermsPrivacyRules